Therapy Areas: Oncology
Karyopharm reports topline Phase 3 trial results in endometrial cancer
31 July 2026 - Karyopharm Therapeutics Inc (Nasdaq:KPTI), a commercial-stage pharmaceutical company developing novel cancer therapies, on Thursday announced topline results from its Phase 3 XPORT-EC-0...
Proteotype unveils Alchemi platform for blood-based multi-cancer test Enlighten
31 July 2026 - Portugal-based Proteotype Diagnostics Unipessoal LDA on Thursday unveiled Alchemi, its proprietary data and clinical workflow platform being developed for Enlighten, the company's ...
10x Genomics and Lausanne University Hospital to collaborate on cancer care research
30 July 2026 - Life science technology company 10x Genomics Inc (Nasdaq:TXG) on Wednesday announced a research collaboration with Lausanne University Hospital (CHUV), a Swiss academic medical centre, ...
AbCellera and Vertex agree collaboration to develop multispecific T-cell engagers
29 July 2026 - Clinical-stage biotechnology company AbCellera Biologics Inc (Nasdaq:ABCL) announced on Wednesday that it has entered into a collaboration with biopharmaceutical company Vertex Pharmace...
Hemogenyx partners with Lithuanian cancer centre on HG-CT-1 research and clinical programme
29 July 2026 - Biopharmaceutical group Hemogenyx Pharmaceuticals plc (LSE: HEMO) reported on Wednesday that it has signed a letter of intent with the National Cancer Centre at Vilnius University Hospi...
Lantern Pharma advances EMA-cleared Phase 1b/2 bladder cancer trial for LP-184
28 July 2026 - Clinical-stage, AI-native biopharma company Lantern Pharma Inc (NASDAQ:LTRN) said on Tuesday that the European Medicines Agency (EMA) has cleared an investigator-initiated Phase 1b/2 cl...